Neurovascular Devices Market To Witness Rapid Development

The neurovascular devices market is evolving rapidly as healthcare providers increase the use of minimally invasive procedures for stroke, cerebral aneurysms, and other cerebrovascular conditions. AI is becoming an important supporting technology in this transformation, particularly in medical imaging, stroke detection, treatment planning, and procedural decision support. AI-enabled platforms can help clinicians analyze complex neurological images and identify potential vascular abnormalities, while advanced imaging technologies can support faster treatment decisions.

At the device level, manufacturers are focusing on neurothrombectomy devices, aspiration catheters, embolization coils, flow diverters, intracranial stents, microcatheters, and advanced neurovascular access systems. The combination of AI, advanced imaging, robotic-assisted intervention, and next-generation catheter technologies is creating opportunities for more precise and efficient neurointerventional procedures. Grand View Research identifies increasing disease prevalence, technological advancement, and the growing preference for minimally invasive treatment as important factors shaping the market.

Key Market Projections (2026 to 2033)

According to Grand View Research, the global neurovascular devices market was valued at USD 7.8 billion in 2025 and is estimated to reach USD 8.2 billion in 2026. The market is projected to reach USD 11.9 billion by 2033, growing at a CAGR of 5.4% from 2026 to 2033. North America held the largest regional share at 30.2% in 2025, while Asia Pacific is expected to record the fastest growth during the forecast period.

The growing burden of stroke is a major contributor to market expansion. According to the Global Stroke Fact Sheet 2024 cited by Grand View Research, more than 12 million new strokes occur annually worldwide, while approximately one in four people globally is expected to experience a stroke during their lifetime. This large patient population is creating demand for mechanical thrombectomy devices, clot retrieval systems, aspiration devices, microcatheters, and other technologies used in neurovascular interventions.

Download a free sample copy of the Neurovascular Devices market report to understand detailed coverage and inclusions in the final report

Core Drivers and Technology Trends

The increasing prevalence of stroke, cerebral aneurysms, arteriovenous malformations, and other cerebrovascular disorders is one of the strongest market drivers. Healthcare providers require technologies that can support rapid diagnosis and effective intervention, particularly for acute ischemic stroke where treatment speed is critical. The expansion of specialized stroke centers and neurointerventional facilities is also increasing demand for advanced devices.

The shift toward minimally invasive neurointerventional procedures is another important trend. Catheter-based treatments can provide alternatives to more invasive surgical approaches and can support faster recovery in suitable patients. As a result, thrombectomy, embolization, coiling, flow diversion, and other endovascular procedures are gaining wider clinical adoption.

Segment and Regional Breakdown

• By device, cerebral embolization and aneurysm coiling devices accounted for the largest share of 37.7% in 2025. This category includes embolic coils, flow diversion coils, and liquid embolic agents. Continuous research into advanced aneurysm treatment technologies is supporting demand for these devices. The neurothrombectomy devices segment is expected to register the fastest growth, supported by rising acute ischemic stroke cases and increasing industry investment in thrombectomy technologies.
• By therapeutic application, stroke represented the largest segment with a 57.0% revenue share in 2025. The segment is supported by the global stroke burden and increasing adoption of devices designed for rapid clot removal. The cerebral aneurysm segment is projected to grow at the fastest rate, driven by increased detection, greater use of minimally invasive endovascular therapies, and advances in embolization and flow diversion technologies.
• By end use, hospitals dominated the market with a 70.9% revenue share in 2025. Hospitals perform a large proportion of neurovascular procedures and generally have the specialized infrastructure, imaging equipment, and trained professionals required for complex interventions. Ambulatory surgery centers, emergency care centers, and other alternative healthcare settings are expected to gain importance as healthcare systems focus on minimally invasive and cost-efficient procedures.

Looking for more specific insights? Customize this report to suite your business needs

Leading Industry Players

Major companies profiled by Grand View Research include Medtronic, Stryker, Johnson & Johnson and its affiliates, Penumbra, Inc., MicroPort Scientific Corporation, Terumo Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., NeuroSafe Medical Co., Ltd., Rapid Medical, Evasc Neurovascular Enterprises, Lepu Medical Technology, Acandis GmbH, and phenox GmbH.

Competition is focused on product innovation, regulatory approvals, clinical validation, physician education, strategic partnerships, and regional expansion. The industry is also seeing increased merger and acquisition activity as established companies seek access to innovative neurovascular technologies. Grand View Research reports that Boston Scientific announced an agreement to acquire Penumbra in January 2026, strengthening its position in mechanical thrombectomy and neurovascular technologies.

Purchase and Research Considerations

If you are looking to purchase or analyze the neurovascular devices market, important factors include device category, clinical application, regulatory status, product performance, reimbursement, hospital demand, procedural volumes, and regional availability. For procurement and market research, neurothrombectomy systems, aspiration catheters, embolization devices, flow diverters, aneurysm coiling systems, intracranial stents, and advanced microcatheters represent important areas to evaluate. AI-supported imaging and robotic-assisted intervention should also be monitored as emerging technologies.

Explore our dedicated business services:

• US Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.